![Rupprecht von Mentzingen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Rupprecht von Mentzingen is a Managing Director at BayernLB Capital Partner GmbH.
He is on the Board of Directors at BayernLB Capital Partner GmbH.
Anciens postes connus de Rupprecht von Mentzingen
| Sociétés | Poste | Fin |
|---|---|---|
BayernLB Capital Partner GmbH
 BayernLB Capital Partner GmbH Investment ManagersFinance BayTech invests in early-stage technology and life sciences companies in Western Europe. The firm targets high-growth startups primarily in Germany and France, and focuses on sectors including communications, software, semiconductors, internet-enabled businesses, medical technology and biotechnology. They seek to invest in potential international market leaders. Their investment criteria include a knowledgeable management team, a potential for high-growth in an attractive market, a sustainable competitive advantage and a clear exit opportunity via IPO or trade sale within five years. BayTech's investment approach is hands-on from day one. The firm's strategy includes getting involved in the decision processes of a potential investee before committing capital, to actively shape their strategy and refine their business plan. The firm initially invests between EUR 1 and 3 million, either as the lead investor or in syndication. They may participate in subsequent financing rounds as well. Board representation is an investment prerequisite. | President | 24/08/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
BayernLB Capital Partner GmbH
BayernLB Capital Partner GmbH Investment ManagersFinance BayTech invests in early-stage technology and life sciences companies in Western Europe. The firm targets high-growth startups primarily in Germany and France, and focuses on sectors including communications, software, semiconductors, internet-enabled businesses, medical technology and biotechnology. They seek to invest in potential international market leaders. Their investment criteria include a knowledgeable management team, a potential for high-growth in an attractive market, a sustainable competitive advantage and a clear exit opportunity via IPO or trade sale within five years. BayTech's investment approach is hands-on from day one. The firm's strategy includes getting involved in the decision processes of a potential investee before committing capital, to actively shape their strategy and refine their business plan. The firm initially invests between EUR 1 and 3 million, either as the lead investor or in syndication. They may participate in subsequent financing rounds as well. Board representation is an investment prerequisite. | Finance |
